RANOK THERAPEUTICS

ranok-therapeutics-logo

Ranok is a privately held, pre clinical stage bio company that is pioneering an innovative targeted protein degradation technology.

#SimilarOrganizations #People #Financial #Website #More

RANOK THERAPEUTICS

Social Links:

Industry:
Biotechnology

Founded:
2018-01-01

Address:
Hangzhou, Zhejiang, China

Country:
China

Website Url:
http://www.ranoktherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
0571-86630936

Email Addresses:
[email protected]

Total Funding:
50 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF ASP.NET IIS DigiCert SSL IIS 8 Encryption Everywhere Alibaba HiChina DNS


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Current Employees Featured

kevin-p-foley_image

Kevin P. Foley`
Kevin P. Foley` Co-founder & Chief Scientific Officer @ Ranok Therapeutics
Co-founder & Chief Scientific Officer

weiwen-ying_image

Weiwen Ying
Weiwen Ying Founder and CEO @ Ranok Therapeutics
Founder and CEO
2018-07-01

Founder


kevin-p-foley_image

Kevin P. Foley`

weiwen-ying_image

Weiwen Ying

Investors List

wu-capital_image

Wu Capital

Wu Capital investment in Series B - Ranok Therapeutics

shanghai-healthcare-capital_image

Shanghai Healthcare Capital

Shanghai Healthcare Capital investment in Series B - Ranok Therapeutics

zhongguancun-kaiyuan-capital_image

Zhongguancun Kaiyuan Capital

Zhongguancun Kaiyuan Capital investment in Series B - Ranok Therapeutics

lapam-capital_image

Lapam Capital

Lapam Capital investment in Series B - Ranok Therapeutics

lc-ventures_image

LC Ventures

LC Ventures investment in Seed Round - Ranok Therapeutics

tf-capital_image

TF Capital

TF Capital investment in Seed Round - Ranok Therapeutics

med-fine-capital_image

Med-Fine Capital

Med-Fine Capital investment in Seed Round - Ranok Therapeutics

Official Site Inspections

http://www.ranoktherapeutics.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K

  • Host name: 8.45.52.203
  • IP address: 8.45.52.203
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ranok Therapeutics"

Ranok Therapeutics Co. Ltd.-HOME

Ranok is a privately held, clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel …See details»

Ranok Therapeutics Co. Ltd.-ABOUT RANOK

Ranok is a privately held, clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics.See details»

Ranok Therapeutics Co. Ltd.-Board of Directors

Mr. Wang is a co-founder of Ranok Therapeutics and also Chairman and CEO of Shanghai UNIONLAB Co. Ltd., a rapidly growing oncology-focused clinical CRO in China. Prior to this, …See details»

Ranok Therapeutics - Crunchbase Company Profile

Ranok Therapeutics is a biotechnology company that is pioneering an innovative targeted protein degradation technology. View contacts for Ranok Therapeutics to access new leads and connect with decision-makers.See details»

Ranok Therapeutics - LinkedIn

Ranok is a privately held, clinical-stage biopharmaceutical company that is pioneering CHAMP®, an innovative approach to targeted protein degradation for the discovery and development of novel...See details»

Weiwen Ying - Co-Founder & CEO at Ranok Therapeutics - The Org

Dr. Ying is the inventor of Ranok’s innovative targeted protein degradation technology. He was most recently Co-founder and President of the immuno-oncology startup Capten Therapeutics …See details»

Ranok Therapeutics Announces Initiation of Patient

Aug 24, 2022 · Study will evaluate the first protein degrader developed using Ranok’s innovative CHAMPâ„¢ technology in patients with advanced solid tumors or diffuse large B-cell lymphoma (DLBCL)See details»

Ranok Therapeutics Announces U.S. FDA Clearance to …

Jan 24, 2022 · Ranok is a privately held biopharmaceutical company that is pioneering CHAMP â„¢, an innovative approach to targeted protein degradation for the discovery and development of novel therapeutics.See details»

Ranok Therapeutics Announces U.S. FDA Clearance to Proceed

Jan 24, 2022 · Ranok Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for RNK05047, a …See details»

Ranok Therapeutics Co. Ltd.-Media

Jun 23, 2024 · [email protected] WELCOME to RANOK THERAPEUTICS. We are pioneering the next generation of targeted protein degradation technology to deliver …See details»

Ranok Therapeutics Announces Agreement with Pfizer …

Nov 29, 2021 · Ranok Therapeutics announces agreement with Pfizer on Targeted Protein Degradation; proposed research will apply Ranok’s innovative CHAMPâ„¢ technology to a selected cancer drug target.See details»

Ranok Therapeutics Expands Clinical Testing of CHAMP® BRD4 …

Mar 11, 2024 · BOSTON & HANGZHOU, China, March 11, 2024 -- (BUSINESS WIRE)--Ranok Therapeutics, a clinical-stage biopharmaceutical company that is developing a novel approach …See details»

Ranok Therapeutics Co. Ltd.-About Our Name

[email protected] WELCOME to RANOK THERAPEUTICS. We are pioneering the next generation of targeted protein degradation technology to deliver transformative medicines …See details»

Ranok Therapeutics Secures $40 Million Series B ... - Business Wire

Aug 18, 2021 · Ranok is a privately held, emerging biopharmaceutical company that is pioneering its proprietary CHAMP platform technology, an innovative approach to targeted protein …See details»

Ranok Therapeutics Expands Clinical Testing of CHAMP® BRD4

Mar 11, 2024 · Ranok is a privately held biopharmaceutical company that is pioneering CHAMP ®, an innovative approach to targeted protein degradation for the discovery and development …See details»

Ranok Therapeutics Expands Clinical Testing of CHAMP® BRD4 …

Mar 11, 2024 · Ranok is a privately held biopharmaceutical company that is pioneering CHAMP ®, an innovative approach to targeted protein degradation for the discovery and development …See details»

Ranok Therapeutics Co. Ltd.-TECHNOLOGY

[email protected] WELCOME to RANOK THERAPEUTICS. We are pioneering the next generation of targeted protein degradation technology to deliver transformative medicines …See details»

Ranok Therapeutics to Present at BMO Biopharma Spotlight Series …

Feb 15, 2022 · Ranok is a privately held biopharmaceutical company that is pioneering CHAMPâ„¢, an innovative approach to targeted protein degradation for the discovery and …See details»

Ranok Therapeutics Announces Agreement with Pfizer on

Nov 29, 2021 · BOSTON & HANGZHOU, China-- ( BUSINESS WIRE )-- Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing …See details»

Ranok Therapeutics to Present at the American Association for …

Apr 6, 2021 · Ranok is a privately held, emerging biopharmaceutical company that is pioneering its proprietary CHAMPTM platform technology, an innovative approach to targeted protein …See details»

linkstock.net © 2022. All rights reserved